Second blood-vessel-growth protein implicated in PDR
June 3rd 2015Targeting the blood-vessel-growth protein angiopoietin-like 4 (ANGPTL4) along with anti-vascular endothelial growth factor (VEGF) therapy could increase the effectiveness of treatments for the prevention of proliferative diabetic retinopathy (PDR), according to researchers at The Johns Hopkins University and the University of Maryland.
No capsule support? Anterior chamber versus posterior chamber IOL
June 1st 2015Take-home message: When considering IOL implantation options when there is a lack of capsular support, cataract surgeons should use the approach with which they are most comfortable. They should also continue to learn about new available techniques.
Magnitude, axis of astigmatism vital to toric IOL alignment, but no consensus on best measure
June 1st 2015Though it is generally agreed that accurate identification of the magnitude and axis of astigmatism is essential in order to choose the right toric power and correctly position it, there is no strong consensus about which measurement is best to base magnitude and axis decisions. Results from a recent clinical survey support this trend.